DA32 Life Science Tech Acquisition Corp.
SEC CIK 1863294 · DALS · last insider filing 2023-08-10
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Crandell Keith | Director | filed 2021 - 2023 |
| Deerfield Management Company, L.P. (Series C) | Director | filed 2021 - 2023 |
| Deerfield Mgmt L.P. | Director | filed 2021 - 2023 |
| Deerfield Partners, LP | Director | filed 2021 - 2023 |
| Flynn James E | Director | filed 2021 - 2023 |
| Maris William J | Director | filed 2021 - 2021 |
| Section 32 Fund 3, LP | Director | filed 2021 - 2021 |
| Section 32 GP 3, LLC | Director | filed 2021 - 2021 |
| Hrusovsky E Kevin | Director | filed 2021 - 2021 |
| Roelofs Nicolas H PHD | Director | filed 2021 - 2021 |
| Kafka Steven J. | Director · Chief Executive Officer | filed 2021 - 2021 |
| Aspinall Mara G. | Director | filed 2021 - 2021 |
| Elbardissi Andrew | Director | filed 2021 - 2021 |
| Lai Angela | Director | filed 2021 - 2021 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Wolfe Chris | Chief Financial Officer | filed 2021 - 2021 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.